Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

The Impact of TCR Signal Strength on Resident Memory T Cell Formation during Influenza Virus Infection.

Fiege JK, Stone IA, Fay EJ, Markman MW, Wijeyesinghe S, Macchietto MG, Shen S, Masopust D, Langlois RA.

J Immunol. 2019 Aug 15;203(4):936-945. doi: 10.4049/jimmunol.1900093. Epub 2019 Jun 24.

PMID:
31235552
2.

Engineered Small-Molecule Control of Influenza A Virus Replication.

Fay EJ, Aron SL, Stone IA, Waring BM, Plemper RK, Langlois RA.

J Virol. 2018 Dec 10;93(1). pii: e01677-18. doi: 10.1128/JVI.01677-18. Print 2019 Jan 1.

3.

MicroRNA-Attenuated Virus Vaccines.

Fay EJ, Langlois RA.

Noncoding RNA. 2018 Oct 2;4(4). pii: E25. doi: 10.3390/ncrna4040025. Review.

4.

Distinct antiviral signatures revealed by the magnitude and round of influenza virus replication in vivo.

Sjaastad LE, Fay EJ, Fiege JK, Macchietto MG, Stone IA, Markman MW, Shen S, Langlois RA.

Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):9610-9615. doi: 10.1073/pnas.1807516115. Epub 2018 Sep 4.

5.

MicroRNA-Based Attenuation of Influenza Virus across Susceptible Hosts.

Waring BM, Sjaastad LE, Fiege JK, Fay EJ, Reyes I, Moriarity B, Langlois RA.

J Virol. 2018 Jan 2;92(2). pii: e01741-17. doi: 10.1128/JVI.01741-17. Print 2018 Jan 15.

Supplemental Content

Support Center